Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Umbrella, Randomized, Controlled, Pre Operative Trial Testing Integrative Subtype Targeted Therapeutics in Estrogen Receptor Positive, HER2-Negative Breast Cancer

NCT05101564 is registered in ClinicalTrials.gov with Jennifer Lee Caswell-Jin as lead sponsor.

NCT NCT05101564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05101564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Umbrella, Randomized, Controlled, Pre Operative Trial Testing Integrative Subtype Targeted Therapeutics in Estrogen Receptor Positive, HER2-Negative Breast Cancer
Lead sponsor
Jennifer Lee Caswell-Jin
Phase
Phase 2
Overall status
Completed
Start date
March 20, 2023
Completion date
June 3, 2024
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, er positive breast cancer, her2-negative breast cancer